Bicycle Therapeutics (BCYC) Receivables: 2019-2025
Historic Receivables for Bicycle Therapeutics (BCYC) over the last 3 years, with Mar 2025 value amounting to $46.4 million.
- Bicycle Therapeutics' Receivables was N/A to $46.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $227.5 million, marking a year-over-year change of. This contributed to the annual value of $21.2 million for FY2022, which is 78.06% up from last year.
- According to the latest figures from Q1 2025, Bicycle Therapeutics' Receivables is $46.4 million, which was down 0.65% from $46.7 million recorded in Q2 2024.
- In the past 5 years, Bicycle Therapeutics' Receivables registered a high of $76.5 million during Q1 2023, and its lowest value of $11.9 million during Q4 2021.
- Over the past 3 years, Bicycle Therapeutics' median Receivables value was $52.3 million (recorded in 2023), while the average stood at $56.9 million.
- Per our database at Business Quant, Bicycle Therapeutics' Receivables soared by 389.58% in 2023 and then decreased by 19.49% in 2024.
- Over the past 5 years, Bicycle Therapeutics' Receivables (Quarterly) stood at $11.9 million in 2021, then spiked by 78.06% to $21.2 million in 2022, then skyrocketed by 120.69% to $58.0 million in 2023, then decreased by 19.49% to $46.7 million in 2024, then reached $46.4 million in 2025.
- Its Receivables stands at $46.4 million for Q1 2025, versus $46.7 million for Q2 2024 and $58.0 million for Q2 2023.